2024-09-28

FDA approves Bristol Myers Squibb’s schizophrenia drug

Bristol Myers Squibb’s Cobenfy drug Courtesy: Bristol Myers Squibb The Food and Drug Administration on Thursday approved Bristol Myers Squibb‘s highly anticipated schizophrenia drug Cobenfy, the first novel type of treatment for the debilitating, chronic mental disorder in more than seven decades.  Schizophrenia affects how a person thinks, feels and behaves, and can cause paranoia, delusions, hallucinations, and changes…

Read More

2024-09-06

Court approves plan to exit Chapter 11

The exterior of a Red Lobster restaurant in Austin, Texas, on May 20, 2024. Brandon Bell | Getty Images A bankruptcy court approved Red Lobster’s plan to exit Chapter 11, putting the seafood chain one step closer to exiting bankruptcy. The company, known for its seafood offerings and cheddar biscuits, filed for bankruptcy protection in May. Red Lobster had…

Read More